AKBM Fundamental Analysis - AKER BIOMARINE ASA

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to AKBM. AKBM was compared to 59 industry peers in the Food Products industry. AKBM scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AKBM is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

AKBM had negative earnings in the past year.

In the past year AKBM had a positive cash flow from operations.

In multiple years AKBM reported negative net income over the last 5 years.

Of the past 5 years AKBM 4 years had a positive operating cash flow.

1.2 Ratios

AKBM has a Return On Assets of 46.54%. This is amongst the best in the industry. AKBM outperforms 100.00% of its industry peers.

AKBM has a better Return On Equity (103.68%) than 100.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	46.54%
ROE	103.68%
ROIC	N/A

ROA(3y)15.56%

ROA(5y)8.97%

ROE(3y)34.62%

ROE(5y)20.05%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

AKBM has a better Profit Margin (78.80%) than 100.00% of its industry peers.

AKBM has a Gross Margin of 31.82%. This is in the lower half of the industry: AKBM underperforms 61.02% of its industry peers.

In the last couple of years the Gross Margin of AKBM has declined.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	78.8%
GM	31.82%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.1%

GM growth 5Y-2.15%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

AKBM does not have a ROIC to compare to the WACC, probably because it is not profitable.

AKBM has about the same amout of shares outstanding than it did 1 year ago.

The number of shares outstanding for AKBM remains at a similar level compared to 5 years ago.

The debt/assets ratio for AKBM has been reduced compared to a year ago.

2.2 Solvency

AKBM has an Altman-Z score of 0.99. This is a bad value and indicates that AKBM is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of 0.99, AKBM is not doing good in the industry: 79.66% of the companies in the same industry are doing better.

A Debt/Equity ratio of 0.81 indicates that AKBM is somewhat dependend on debt financing.

The Debt to Equity ratio of AKBM (0.81) is worse than 62.71% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.81
Debt/FCF	N/A
Altman-Z	0.99

ROIC/WACCN/A

WACC7.98%

2.3 Liquidity

AKBM has a Current Ratio of 3.79. This indicates that AKBM is financially healthy and has no problem in meeting its short term obligations.

With an excellent Current ratio value of 3.79, AKBM belongs to the best of the industry, outperforming 94.92% of the companies in the same industry.

A Quick Ratio of 1.98 indicates that AKBM should not have too much problems paying its short term obligations.

AKBM's Quick ratio of 1.98 is amongst the best of the industry. AKBM outperforms 89.83% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.79
Quick Ratio	1.98

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for AKBM have decreased strongly by -157.14% in the last year.

Looking at the last year, AKBM shows a very negative growth in Revenue. The Revenue has decreased by -31.76% in the last year.

AKBM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.81% yearly.

EPS 1Y (TTM)-157.14%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-144.44%

Revenue 1Y (TTM)-31.76%

Revenue growth 3Y5.13%

Revenue growth 5Y16.81%

Sales Q2Q%-37.27%

3.2 Future

The Earnings Per Share is expected to grow by 91.59% on average over the next years. This is a very strong growth

Based on estimates for the next years, AKBM will show a quite strong growth in Revenue. The Revenue will grow by 12.35% on average per year.

EPS Next Y227.5%

EPS Next 2Y107.24%

EPS Next 3Y103.08%

EPS Next 5Y91.59%

Revenue Next Year-22.73%

Revenue Next 2Y-18.41%

Revenue Next 3Y-9.06%

Revenue Next 5Y12.35%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AKBM. In the last year negative earnings were reported.

Based on the Price/Forward Earnings ratio of 63.65, the valuation of AKBM can be described as expensive.

AKBM's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. AKBM is more expensive than 72.88% of the companies in the same industry.

The average S&P500 Price/Forward Earnings ratio is at 22.15. AKBM is valued rather expensively when compared to this.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	63.65

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AKBM is valued a bit more expensive than 72.88% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	16.14

4.3 Compensation for Growth

AKBM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

AKBM's earnings are expected to grow with 103.08% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y107.24%

EPS Next 3Y103.08%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for AKBM!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AKER BIOMARINE ASA

OSL:AKBM (5/30/2025, 7:00:00 PM)

59.5

+0.1 (+0.17%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryFood Products

Earnings (Last)04-30 2025-04-30

Earnings (Next)07-11 2025-07-11

Inst Owners8.8%

Inst Owner ChangeN/A

Ins Owners3.14%

Ins Owner ChangeN/A

Market Cap5.22B

Analysts82.22

Price Target71.4 (20%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend43.4

Dividend Growth(5Y)N/A

DP206.99%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-281.86%

Min EPS beat(2)-684.31%

Max EPS beat(2)120.59%

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-10.8%

Min Revenue beat(2)-13.17%

Max Revenue beat(2)-8.42%

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-9.68%

PT rev (3m)-9.68%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-30.77%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-5.44%

Revenue NY rev (3m)-5.83%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	63.65
P/S	2.24
P/FCF	N/A
P/OCF	42
P/B	2.95
P/tB	10.15
EV/EBITDA	16.14

EPS(TTM)-0.41

EYN/A

EPS(NY)0.93

Fwd EY1.57%

FCF(TTM)-1.27

FCFYN/A

OCF(TTM)1.42

OCFY2.38%

SpS26.57

BVpS20.19

TBVpS5.86

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	46.54%
ROE	103.68%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	78.8%
GM	31.82%
FCFM	N/A

ROA(3y)15.56%

ROA(5y)8.97%

ROE(3y)34.62%

ROE(5y)20.05%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.1%

GM growth 5Y-2.15%

F-Score6

Asset Turnover0.59

Health

		Industry Rank	Sector Rank
Debt/Equity	0.81
Debt/FCF	N/A
Debt/EBITDA	3.52
Cap/Depr	48.33%
Cap/Sales	10.1%
Interest Coverage	N/A
Cash Conversion	30.58%
Profit Quality	N/A
Current Ratio	3.79
Quick Ratio	1.98
Altman-Z	0.99

F-Score6

WACC7.98%

ROIC/WACCN/A

Cap/Depr(3y)77.43%

Cap/Depr(5y)88.04%

Cap/Sales(3y)14.31%

Cap/Sales(5y)16.42%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-157.14%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-144.44%

EPS Next Y227.5%

EPS Next 2Y107.24%

EPS Next 3Y103.08%

EPS Next 5Y91.59%

Revenue 1Y (TTM)-31.76%

Revenue growth 3Y5.13%

Revenue growth 5Y16.81%

Sales Q2Q%-37.27%

Revenue Next Year-22.73%

Revenue Next 2Y-18.41%

Revenue Next 3Y-9.06%

Revenue Next 5Y12.35%

EBIT growth 1Y-249.06%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year177.08%

EBIT Next 3Y69.2%

EBIT Next 5YN/A

FCF growth 1Y-473.68%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-74.26%

OCF growth 3Y155.79%

OCF growth 5Y-0.17%

AKER BIOMARINE ASA (AKBM.OL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens